CA2101919A1 - Specificite de l'integrine pour la proteine tat de vih - Google Patents

Specificite de l'integrine pour la proteine tat de vih

Info

Publication number
CA2101919A1
CA2101919A1 CA002101919A CA2101919A CA2101919A1 CA 2101919 A1 CA2101919 A1 CA 2101919A1 CA 002101919 A CA002101919 A CA 002101919A CA 2101919 A CA2101919 A CA 2101919A CA 2101919 A1 CA2101919 A1 CA 2101919A1
Authority
CA
Canada
Prior art keywords
binding
integrin
tat
hiv tat
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002101919A
Other languages
English (en)
Inventor
Bruce E. Vogel
Flossie Y. Wong-Staal
Erkki I. Ruoslahti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2101919A1 publication Critical patent/CA2101919A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002101919A 1991-02-14 1992-02-13 Specificite de l'integrine pour la proteine tat de vih Abandoned CA2101919A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65642491A 1991-02-14 1991-02-14
US07/656,424 1991-02-14

Publications (1)

Publication Number Publication Date
CA2101919A1 true CA2101919A1 (fr) 1992-08-15

Family

ID=24632975

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002101919A Abandoned CA2101919A1 (fr) 1991-02-14 1992-02-13 Specificite de l'integrine pour la proteine tat de vih

Country Status (5)

Country Link
EP (1) EP0571549A4 (fr)
JP (1) JPH06508603A (fr)
AU (1) AU1449792A (fr)
CA (1) CA2101919A1 (fr)
WO (1) WO1992014755A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015224A1 (fr) * 1990-03-30 1991-10-17 Smithkline Beecham Corporation Inhibition de la maladie associee a l'infection due au virus de l'immunodeficience
FR2731355B1 (fr) * 1995-03-08 1997-05-30 Neovacs Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
WO1996027389A1 (fr) * 1995-03-08 1996-09-12 Neovacs Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps, procede de preparation et compositions pharmaceutiques les renfermant
US6200575B1 (en) 1996-03-07 2001-03-13 Neovacs Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them
US5891994A (en) 1997-07-11 1999-04-06 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
US6399067B1 (en) 2000-04-28 2002-06-04 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
US7563437B2 (en) 2005-02-15 2009-07-21 Thymon, Llc Methods and compositions for impairing multiplication of HIV-1
US10376549B2 (en) * 2015-01-20 2019-08-13 Adcure Biotechnologies, Llc. Detargeted adenovirus variants and related methods
US9982276B2 (en) 2015-03-12 2018-05-29 Adcure Biotechnologies, Llc. Penton-mutated, integrin-retargeted adenovirus vectors with reduced toxicity and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012461A1 (fr) * 1988-06-16 1989-12-28 St. Louis University Antagonistes de proteines de transactivation virales

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site

Also Published As

Publication number Publication date
WO1992014755A1 (fr) 1992-09-03
EP0571549A4 (fr) 1995-03-15
EP0571549A1 (fr) 1993-12-01
AU1449792A (en) 1992-09-15
JPH06508603A (ja) 1994-09-29

Similar Documents

Publication Publication Date Title
Vogel et al. A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin.
US5817750A (en) Structural mimics of RGD-binding sites
Cheresh et al. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells
Brake et al. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat.
Pfaff et al. Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI
Koivunen et al. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins
Gullberg et al. Analysis of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrins in cell‐‐collagen interactions: identification of conformation dependent alpha 1 beta 1 binding sites in collagen type I.
US5912234A (en) Integrin-binding peptides
US5268358A (en) PDGF receptor blocking peptides
US5705606A (en) Peptides derived from GPIIIa
US5589570A (en) Integrin alpha subunit cytoplasmic domain polypeptides and methods
JPH05502228A (ja) インテグリン―リガンド結合を阻害するペプチドおよび抗体
SK284586B6 (sk) Použitie alfa_v_beta3 antagonistu na prípravu liečiva
Underwood et al. Evidence for the location of a binding sequence for the α 2 β 1 integrin of endothelial cells, in the β 1 subunit of laminin
CA2101919A1 (fr) Specificite de l'integrine pour la proteine tat de vih
Mitsios et al. Effect of synthetic peptides corresponding to residues 313–332 of the αIIb subunit on platelet activation and fibrinogen binding to αIIbβ3
WO1996008513A1 (fr) Derives de cytotactine stimulant la connexion neuronale et la croissance des axones et des dendrites, leurs procedes de preparation et d'utilisation
EP0972781B1 (fr) Polypeptides de la protéine S et leurs utilisations
WO1996008513A9 (fr) Derives de cytotactine stimulant la connexion neuronale et la croissance des axones et des dendrites, leurs procedes de preparation et d'utilisation
US6124260A (en) Inhibition of smooth muscle cell migration by Tenascin-C peptides
WO2001079144A2 (fr) Fyn kinase comme cible de modulation de la transduction des signaux medies par l'integrine
US7122324B2 (en) Vitro methods for determining in vivo thrombotic events
US5003044A (en) Peptide inhibitors of motor neuron attachment to s-laminin
WO1993001209A1 (fr) Polypeptides de proteines s et leurs utilisations
Madden et al. A peptide derived from neutrophil inhibitory factor (NIF) blocks neutrophil adherence to endothelial cells

Legal Events

Date Code Title Description
FZDE Dead